Taken together, these data suggest that increased interaction between USP5 and ORP8 facilitates the accumulation of ORP8 via USP5-mediated deubiquitination, leading to aggravation of ER stress in brigatinib-treated CRC cells. The gene discussed is OSBPL8; the disease is colorectal carcinoma.